Position in EYPT
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$345,917
+$43,776 QoQ
Shares Held
24,190
+3.2% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 20 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cyndeo Wealth Partners, LLC holds $5,325,846 across 6 Biotechnology names. EYPT ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
118,444 | $3,722,694 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
25,430 | $430,275 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
676 | $421,513 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
6,978 | $380,580 | |
| 5 | EYPT |
EyePoint, Inc.
This page
|
24,190 | $345,917 | |
| 6 | HURA |
TuHURA Biosciences, Inc./NV
|
10,627 | $24,867 |
All Filings in EYPT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,917 | 24,190 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $302,141 | 23,440 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $420,027 | 22,990 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $316,555 | 22,230 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $134,092 | 14,250 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $136,855 | 25,250 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $126,575 | 16,990 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $100,194 | 12,540 | Shares | Sole | 2024-10-18 | |
| No filing history on record for this holder in this stock. | ||||||